| scholarly article | Q13442814 |
| P2093 | author name string | Fu-er Lu | |
| Li-jun Xu | |||
| San-hua Leng | |||
| P433 | issue | 4 | |
| P921 | main subject | preproinsulin | Q7240673 |
| glucose | Q37525 | ||
| P304 | page(s) | 496-502 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion | |
| P478 | volume | 25 |
| Q39188362 | A 1H-NMR-Based Metabonomic Study on the Anti-Depressive Effect of the Total Alkaloid of Corydalis Rhizoma |
| Q26773570 | A quick overview on some aspects of endocrinological and therapeutic effects of Berberis vulgaris L |
| Q34557477 | AMPK as Target for Intervention in Childhood and Adolescent Obesity |
| Q36512463 | Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance |
| Q51348425 | Antihyperglycemic effect of the traditional Chinese scutellaria–coptis herb couple and its main components in streptozotocin-induced diabetic rats |
| Q51384875 | Beneficial effects of Undaria pinnatifida ethanol extract on diet-induced-insulin resistance in C57BL/6J mice |
| Q58587589 | Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma |
| Q37622726 | Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats |
| Q35684719 | Berberine Improves Glucose Homeostasis in Streptozotocin-Induced Diabetic Rats in Association with Multiple Factors of Insulin Resistance |
| Q85528107 | Berberine Induces Cell Apoptosis through Cytochrome C/Apoptotic Protease-Activating Factor 1/Caspase-3 and Apoptosis Inducing Factor Pathway in Mouse Insulinoma Cells |
| Q64259838 | Berberine Influences Blood Glucose via Modulating the Gut Microbiome in Grass Carp |
| Q35767390 | Berberine Inhibited the Growth of Thyroid Cancer Cell Lines 8505C and TPC1 |
| Q39627023 | Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes |
| Q39547455 | Berberine acutely activates the glucose transport activity of GLUT1 |
| Q84211238 | Berberine acutely inhibits the digestion of maltose in the intestine |
| Q33265122 | Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease |
| Q50746082 | Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. |
| Q34309558 | Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis |
| Q37412690 | Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4. |
| Q37728794 | Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells |
| Q46163975 | Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition |
| Q85029538 | Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro |
| Q51369549 | Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver |
| Q35022545 | Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes |
| Q37203815 | Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKbeta |
| Q28576577 | Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury |
| Q39052677 | Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB. |
| Q39387557 | Berberine‐induced growth inhibition of epithelial ovarian carcinoma cell lines |
| Q98778967 | Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression |
| Q35100360 | Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats |
| Q37981953 | Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease |
| Q57300387 | Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic Rats |
| Q34094808 | Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells |
| Q46532725 | Effect of berberine on expression of hepatocyte nuclear factor-4alpha in rats with fructose-induced insulin resistance |
| Q53264353 | Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats |
| Q37741992 | Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice |
| Q28213567 | Effect of huanglian jiedu decoction ) on glucose transporter 4 expression in adipose and skeletal muscle tissues of insulin resistant rats |
| Q24645248 | Efficacy of berberine in patients with type 2 diabetes mellitus |
| Q24654782 | Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity |
| Q39342467 | Hepatoprotection of Berberine Against Hydrogen Peroxide‐induced Apoptosis by Upregulation of Sirtuin 1 |
| Q79217911 | Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence |
| Q37236039 | In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine |
| Q53130900 | Interaction of Herbal Compounds with Biological Targets: A Case Study with Berberine |
| Q44510344 | Jiaotai Pill enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats |
| Q41332584 | JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial |
| Q40571635 | Myocardial Salvaging Effects of Berberine in Experimental Diabetes Co-Existing with Myocardial Infarction |
| Q34045439 | Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes. |
| Q34563014 | Preparative separation of quaternary ammonium alkaloids from Corydalis yanhusuo W. T. Wang by pH‐zone‐refining counter‐current chromatography |
| Q37210162 | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice |
| Q36464474 | Protective effects of berberine on high fat-induced kidney damage by increasing serum adiponectin and promoting insulin sensitivity |
| Q57490795 | Role of Intestinal Bitter Sensing in Enteroendocrine Hormone Secretion and Metabolic Control |
| Q37227111 | Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis |
| Q37544305 | Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects |
| Q55111061 | The Effects of Berberis Vulgaris Juice on Insulin Indices in Women with Benign Breast Disease: A Randomized Controlled Clinical Trial. |
| Q42043970 | The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients |
| Q28078754 | The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease |
| Q33562758 | The protective effect of berberine on β-cell lipoapoptosis |
| Q24657961 | Traditional chinese medicine in treatment of metabolic syndrome |
| Q36988577 | Update on Berberine in Nonalcoholic Fatty Liver Disease |
| Q57177401 | Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis |
Search more.